Preparation method of rivastigmine citrate

A technology of citrate and anhydrous sodium carbonate, which is applied in the direction of carboxylate preparation, carboxylate preparation, sulfonate preparation, etc., can solve the problem of difficult to obtain high-purity rivastigmine, complex synthesis steps and cost Advanced issues, achieve the effect of easy realization of reaction conditions and controllability, improvement of bioavailability, and improvement of bioavailability

Inactive Publication Date: 2019-09-24
ZHEJIANG WANBANG PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Regarding the synthesis of rivastigmine, the prior art mainly prepares rivastigmine bitartrate, and the main method is to use N-methyl-ethylcarbamoyl chloride as the starting material, through Gabriel condensation, amidation, ionization, etc. Conventional synthesis reaction, but the conventional synthesis me...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of rivastigmine citrate
  • Preparation method of rivastigmine citrate
  • Preparation method of rivastigmine citrate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Synthesis of 3-acetylphenyl N-ethyl-N-methylcarbamate

[0042]Under the protection of argon, 3.58 mol of m-hydroxyacetophenone was taken in a microwave reactor, dissolved in THF solution, 6.88 mol of anhydrous sodium carbonate was added under stirring, and 4.26 mol of methylethylcarbamoyl chloride was slowly added dropwise after stirring and dissolving. Control the adding time at about 30min, heat to reflux, turn on the microwave frequency and set it to 3600MHz, react for 8-10h, detect with TLC, track until the raw material point completely disappears, filter out the solid, add 15L of water and 9L of ethyl acetate to the filtrate to divide Three times of extraction, distillation under reduced pressure at 45°C to obtain yellow oil N-ethyl-N-methylcarbamate-3-acetylphenyl ester (abbreviated as KB1), the yield is 85%, and the purity by HPLC is 98.7%

Embodiment 2

[0044] Synthesis of (R)-N-ethyl-N-methylcarbamic acid-3-(1-hydroxyethyl)phenyl ester

[0045] Put it in a microwave reactor under the protection of argon, take 0.25mol of diphenylcoaminoalcohol, dissolve it in anhydrous ethanol solution, add 0.42mol of trimethyl borate dropwise under stirring, control the dropping time at about 20min, and the dropping is completed Continue to react for 1h, add 2.0eq of borane tetrahydrofuran complex dropwise, dropwise for 20-30min, continue to stir for 30min, then slowly add KB1 3.72mol. dissolved in 7.5L of absolute ethanol, the reaction is exothermic, and dropwise The time is 80min, the microwave frequency is set to 80MHz, the synthesis reaction is continued for 16-18h, the reaction is stopped, the solvent is distilled off under reduced pressure, and the light yellow oily substance is obtained; 5L of ethyl acetate is added to the oily substance, and 4L of 1.5mol / L hydrochloric acid is added , stirred for 30min, static layering, retaining the...

Embodiment 3

[0047] Synthesis of free substance of rivastigmine

[0048] Under the protection of argon, place the material in an isotope energy level transition reactor, dissolve 3.8mol of KB2 in tetrahydrofuran solvent, cool down to 0-5°C, add 4.5mol of methanesulfonyl chloride dropwise, add dropwise for 60-80min, and replenish Add 4L of tetrahydrofuran solution, raise the temperature to 20°C, stir for 30 minutes, start the isotope energy level transition, control the temperature at 20°C-25°C and continue stirring for 5 hours, add 4L of water to quench the reaction, distill the solvent under reduced pressure, add 5L of ethyl acetate and stir Extract, separate the water layer, keep the organic layer, cool the organic layer to 0-5°C, add 3L of 2mol / L hydrochloric acid, stir, separate the organic layer, keep the water layer, add 3L of ethyl acetate to the water layer to extract twice, cool down Slowly add 2mol / L sodium hydroxide solution to 0-5°C to adjust the pH to 9-10. Extract with ethyl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of rivastigmine citrate. The method includes the steps that a rivastigmine free compound is obtained through chemical synthesis reaction by means of condensation, CBS asymmetric hydride reduction and acylation under the conditions of isotope energy level transition, high-low-frequency alternating ultrasound and microwave radiation with hydroxyacetophenone and methylaminoformyl chloride as raw materials; finally, the rivastigmine free compound and anhydrous citrate form the rivastigmine citrate. The synthesis and preparation method is high in yield, high in product purity, simple in process and low in cost, few byproducts are generated, the purity of a target product can be improved, and the industrial mass production of the product is facilitated.

Description

technical field [0001] The invention relates to a preparation method of a pharmaceutical compound. Specifically, it is a method for the synthesis and preparation of high-purity rivastigmine citrate. [0002] technical background [0003] Rivastigmine (Rivastigmine), a drug suitable for the treatment of mild and moderate Alzheimer's dementia, has the following structural formula: [0004] [0005] The product was launched in Switzerland in 1997, and later in the United States, Canada, China and many other countries. It belongs to the third generation of drugs for improving choline system function, and is a carbamate acetylcholinesterase (AchE) inhibitor and butyrylcholinesterase (BuchE) inhibitor that selectively acts on the brain. It has become the main drug for the treatment of Alzheimer's disease. In 2006, the U.S. Food and Drug Administration (FDA) approved a new indication of rivastigmine, which is used to treat mild to moderate dementia associated with Parkinson's ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C269/04C07C269/06C07C269/08C07C271/44C07C309/66C07C303/28C07C59/265C07C51/41C07C51/43
CPCC07C51/412C07C51/43C07C269/04C07C269/06C07C269/08C07C303/28C07C271/44C07C309/66C07C59/265
Inventor 金连玉陈安许海军王敬伟闫爽
Owner ZHEJIANG WANBANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap